Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 20/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15296277 | 1.00 | IL23R (0.58) | IL23R | |
| SCHEMBL16727688 | 0.95 | IL23R (0.53) | IL23R | |
| SCHEMBL11933674 | 0.93 | IL23R (0.55) | IL23R | |
| SCHEMBL20809946 | 0.91 | IL23R (0.59) | IL23R | |
| SCHEMBL13532019 | 0.91 | IL23R (0.59) | IL23R | |
| SCHEMBL16727776 | 0.91 | IL23R (0.50) | IL23R | |
| SCHEMBL14845477 | 0.91 | IL23R (0.54) | IL23R | |
| SCHEMBL11988608 | 0.90 | IL23R (0.52) | IL23R | |
| SCHEMBL15773110 | 0.88 | IL23R (0.54) | IL23R | |
| SCHEMBL16501268 | 0.88 | IL23R (0.55) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299030-B2 | Peptide-based compounds | GE HEALTHCARE LIMITED (GB) | 2012-10-30 | — | — | US | disclosed |
| US-20120020882-A1 | PEPTIDE-BASED COMPOUNDS | GE HEALTHCARE AS (NO) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020882-A1 | PEPTIDE-BASED COMPOUNDS | ITGB3, ITGAV, SELPLG | IL23R 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.